|
N-[9-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]benzamide
|
N681813-500mg
|
≥97% |
79896-97-2 |
500mg
|
¥ 2672.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[9-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]benzamide
|
N681813-25g
|
≥97% |
79896-97-2 |
25g
|
¥ 40000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[9-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]benzamide
|
N681813-250mg
|
≥97% |
79896-97-2 |
250mg
|
¥ 1600.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[9-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]benzamide
|
N681813-1g
|
≥97% |
79896-97-2 |
1g
|
¥ 4000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[9-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]benzamide
|
N681813-10g
|
≥97% |
79896-97-2 |
10g
|
¥ 20000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[9-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]benzamide
|
N681813-100mg
|
≥97% |
79896-97-2 |
100mg
|
¥ 1200.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-(bromomethyl)norbornane
|
N681724-5g
|
≥97% |
55932-58-6 |
5g
|
¥ 24000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-(bromomethyl)norbornane
|
N681724-500mg
|
≥97% |
55932-58-6 |
500mg
|
¥ 5328.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-(bromomethyl)norbornane
|
N681724-25g
|
≥97% |
55932-58-6 |
25g
|
¥ 80000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-(bromomethyl)norbornane
|
N681724-250mg
|
≥97% |
55932-58-6 |
250mg
|
¥ 3200.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-(bromomethyl)norbornane
|
N681724-1g
|
≥97% |
55932-58-6 |
1g
|
¥ 8000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-(bromomethyl)norbornane
|
N681724-10g
|
≥97% |
55932-58-6 |
10g
|
¥ 40000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-(bromomethyl)norbornane
|
N681724-100mg
|
≥97% |
55932-58-6 |
100mg
|
¥ 1920.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-(2,2-dimethylpropyl)piperidine-4-carboxamide;hydrochloride
|
N681670-5g
|
≥97% |
2970214-21-0 |
5g
|
¥ 21600.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-(2,2-dimethylpropyl)piperidine-4-carboxamide;hydrochloride
|
N681670-500mg
|
≥97% |
2970214-21-0 |
500mg
|
¥ 5040.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-(2,2-dimethylpropyl)piperidine-4-carboxamide;hydrochloride
|
N681670-25g
|
≥97% |
2970214-21-0 |
25g
|
¥ 80784.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-(2,2-dimethylpropyl)piperidine-4-carboxamide;hydrochloride
|
N681670-250mg
|
≥97% |
2970214-21-0 |
250mg
|
¥ 3520.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-(2,2-dimethylpropyl)piperidine-4-carboxamide;hydrochloride
|
N681670-1g
|
≥97% |
2970214-21-0 |
1g
|
¥ 7200.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-(2,2-dimethylpropyl)piperidine-4-carboxamide;hydrochloride
|
N681670-10g
|
≥97% |
2970214-21-0 |
10g
|
¥ 36720.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-(2,2-dimethylpropyl)piperidine-4-carboxamide;hydrochloride
|
N681670-100mg
|
≥97% |
2970214-21-0 |
100mg
|
¥ 2128.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-(2,2-dimethylpropyl)azetidine-3-carboxamide;hydrochloride
|
N681665-5g
|
≥97% |
2955561-54-1 |
5g
|
¥ 26400.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-(2,2-dimethylpropyl)azetidine-3-carboxamide;hydrochloride
|
N681665-500mg
|
≥97% |
2955561-54-1 |
500mg
|
¥ 6080.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-(2,2-dimethylpropyl)azetidine-3-carboxamide;hydrochloride
|
N681665-250mg
|
≥97% |
2955561-54-1 |
250mg
|
¥ 4160.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-(2,2-dimethylpropyl)azetidine-3-carboxamide;hydrochloride
|
N681665-1g
|
≥97% |
2955561-54-1 |
1g
|
¥ 8800.9
|
期货,请咨询 |
|
0 |
阿拉丁 |